Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Clinical Decision Support System market in this environment.
In terms of revenue, this research report indicated that the global Clinical Decision Support System market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Clinical Decision Support System industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The McKesson Corporation aims at producing XX K Units Clinical Decision Support System in 2020, with XX % production to take place in global market, Cerner Corporation accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Clinical Decision Support System Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Clinical Decision Support System Market
McKesson Corporation
Cerner Corporation
Epic
Zynx Health
MEDITECH
Wolters Kluwer
NextGen
Philips Healthcare
Allscripts Healthcare Solutions
GE Healthcare
Carestream Health
Athenahealth
...
Major Type of Clinical Decision Support System Covered in Prudent Markets report:
Standalone
EHR-CDSS
EHR-CDSS-CPOE
CDSS-CPOE
Application Segments Covered in Prudent Markets Market
Drug Allergy Alerts
Drug Reminders
Drug-Drug Interactions
Clinical Reminders
Clinical Guidelines
Drug Dosing Support
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Clinical Decision Support System Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Standalone -Product Introduction and Major Manufacturers
1.1.2 EHR-CDSS -Product Introduction and Major Manufacturers
1.1.3 EHR-CDSS-CPOE -Product Introduction and Major Manufacturers
1.1.4 CDSS-CPOE -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Clinical Decision Support System Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Clinical Decision Support System Market
3.1.1 Top Companies leading Clinical Decision Support System Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Clinical Decision Support System Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Clinical Decision Support System Market
3.2.1 Top Companies leading Clinical Decision Support System Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Clinical Decision Support System Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Clinical Decision Support System Market
3.3.1 Top Companies leading Clinical Decision Support System Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Clinical Decision Support System Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Clinical Decision Support System Market
3.4.1 Top Companies leading Clinical Decision Support System Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Clinical Decision Support System Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Clinical Decision Support System Market
3.5.1 Top Companies leading Clinical Decision Support System Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Clinical Decision Support System Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Clinical Decision Support System Market
3.6.1 Top Companies leading Clinical Decision Support System Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Clinical Decision Support System Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Clinical Decision Support System Market
3.7.1 Top Companies leading Clinical Decision Support System Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Clinical Decision Support System Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Clinical Decision Support System Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Clinical Decision Support System Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Clinical Decision Support System Sales and Growth Rate (2021-2027)
5.2 Global Clinical Decision Support System Sales Value and Growth Rate (2021-2027)
6 Clinical Decision Support System Competitive Analysis
6.1 McKesson Corporation
6.1.1 McKesson Corporation Company Profiles
6.1.2 McKesson Corporation Product Introduction
6.1.3 McKesson Corporation Clinical Decision Support System Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Cerner Corporation
6.2.1 Cerner Corporation Company Profiles
6.2.2 Cerner Corporation Product Introduction
6.2.3 Cerner Corporation Clinical Decision Support System Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Epic
6.3.1 Epic Company Profiles
6.3.2 Epic Product Introduction
6.3.3 Epic Clinical Decision Support System Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Zynx Health
6.4.1 Zynx Health Company Profiles
6.4.2 Zynx Health Product Introduction
6.4.3 Zynx Health Clinical Decision Support System Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 MEDITECH
6.5.1 MEDITECH Company Profiles
6.5.2 MEDITECH Product Introduction
6.5.3 MEDITECH Clinical Decision Support System Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Wolters Kluwer
6.6.1 Wolters Kluwer Company Profiles
6.6.2 Wolters Kluwer Product Introduction
6.6.3 Wolters Kluwer Clinical Decision Support System Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 NextGen
6.7.1 NextGen Company Profiles
6.7.2 NextGen Product Introduction
6.7.3 NextGen Clinical Decision Support System Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Philips Healthcare
6.8.1 Philips Healthcare Company Profiles
6.8.2 Philips Healthcare Product Introduction
6.8.3 Philips Healthcare Clinical Decision Support System Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Allscripts Healthcare Solutions
6.9.1 Allscripts Healthcare Solutions Company Profiles
6.9.2 Allscripts Healthcare Solutions Product Introduction
6.9.3 Allscripts Healthcare Solutions Clinical Decision Support System Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 GE Healthcare
6.10.1 GE Healthcare Company Profiles
6.10.2 GE Healthcare Product Introduction
6.10.3 GE Healthcare Clinical Decision Support System Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Carestream Health
6.12 Athenahealth
7 Conclusion